lactobionic acid has been researched along with Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Althagafi, II; Habib, SM; Kanwal, T; Maharjan, R; Saifullah, S; Shah, MR; Simjee, SU; Ullah, S | 1 |
| He, L; Tang, R; Wang, J; Wang, X; Wei, B; Yan, GQ | 1 |
| He, L; Tang, R; Wang, J; Wang, X; Wei, B; Yan, G | 1 |
| Cheng, X; Fu, S; Qin, J; Tang, R; Wang, X; Yao, W; Zha, Q | 1 |
| Cai, K; Ding, X; Hu, Y; Li, J; Li, M; Li, P; Liu, J; Luo, Z; Ma, X; Zeng, Y; Zhang, B; Zhang, Q; Zhao, Y | 1 |
| Ma, Y; Mou, Q; Yan, D; Zhu, X | 1 |
6 other study(ies) available for lactobionic acid and Neoplasms
| Article | Year |
|---|---|
Synthesis of lactobionic acid based bola-amphiphiles and its application as nano-carrier for curcumin delivery to cancer cell cultures in-vitro.
Topics: Antineoplastic Agents; Cell Culture Techniques; Curcumin; Disaccharides; Micelles; Nanoparticles; Neoplasms | 2020 |
Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study.
Topics: Antibiotics, Antineoplastic; Bromelains; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chitosan; Disaccharides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Liver Neoplasms; Nanoparticles; Neoplasms | 2017 |
Bromelain-immobilized and lactobionic acid-modified chitosan nanoparticles for enhanced drug penetration in tumor tissues.
Topics: Animals; Antineoplastic Agents; Bromelains; Cell Death; Cell Line, Tumor; Cell Proliferation; Chitosan; Disaccharides; Doxorubicin; Drug Delivery Systems; Enzymes, Immobilized; Gelatin; Humans; Male; Mice, Inbred ICR; Nanoparticles; Neoplasms; Proton Magnetic Resonance Spectroscopy; Tissue Distribution | 2018 |
Acid-degradable lactobionic acid-modified soy protein nanogels crosslinked by ortho ester linkage for efficient antitumor in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Asialoglycoprotein Receptor; Cell Line, Tumor; Cross-Linking Reagents; Disaccharides; Doxorubicin; Drug Carriers; Drug Liberation; Esters; Gels; Humans; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred ICR; Nanoparticles; Neoplasms; Soybean Proteins; Xenograft Model Antitumor Assays | 2018 |
Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
Topics: Animals; Antineoplastic Agents; Apoptosis; beta-Cyclodextrins; Disaccharides; Doxorubicin; Drug Delivery Systems; Endocytosis; Hep G2 Cells; Humans; Intracellular Space; Mice, Nude; Nanoparticles; Neoplasms; Oxidation-Reduction; Porosity; Silicon Dioxide; Solutions | 2014 |
A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disaccharides; Doxorubicin; Drug Delivery Systems; Drug Liberation; Gluconates; Humans; Kidney; Lactones; Ligands; Liver; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Rats, Sprague-Dawley; Tumor Burden | 2016 |